Incidence and mortality of hip fractures in the United States.

CONTEXT Understanding the incidence and subsequent mortality following hip fracture is essential to measuring population health and the value of improvements in health care. OBJECTIVE To examine trends in hip fracture incidence and resulting mortality over 20 years in the US Medicare population. DESIGN, SETTING, AND PATIENTS Observational study using data from a 20% sample of Medicare claims from 1985-2005. In patients 65 years or older, we identified 786,717 hip fractures for analysis. Medication data were obtained from 109,805 respondents to the Medicare Current Beneficiary Survey between 1992 and 2005. MAIN OUTCOME MEASURES Age- and sex-specific incidence of hip fracture and age- and risk-adjusted mortality rates. RESULTS Between 1986 and 2005, the annual mean number of hip fractures was 957.3 per 100,000 (95% confidence interval [CI], 921.7-992.9) for women and 414.4 per 100,000 (95% CI, 401.6-427.3) for men. The age-adjusted incidence of hip fracture increased from 1986 to 1995 and then steadily declined from 1995 to 2005. In women, incidence increased 9.0%, from 964.2 per 100,000 (95% CI, 958.3-970.1) in 1986 to 1050.9 (95% CI, 1045.2-1056.7) in 1995, with a subsequent decline of 24.5% to 793.5 (95% CI, 788.7-798.3) in 2005. In men, the increase in incidence from 1986 to 1995 was 16.4%, from 392.4 (95% CI, 387.8-397.0) to 456.6 (95% CI, 452.0-461.3), and the subsequent decrease to 2005 was 19.2%, to 369.0 (95% CI, 365.1-372.8). Age- and risk-adjusted mortality in women declined by 11.9%, 14.9%, and 8.8% for 30-, 180-, and 360-day mortality, respectively. For men, age- and risk-adjusted mortality decreased by 21.8%, 25.4%, and 20.0% for 30-, 180-, and 360-day mortality, respectively. Over time, patients with hip fracture have had an increase in all comorbidities recorded except paralysis. The incidence decrease is coincident with increased use of bisphosphonates. CONCLUSION In the United States, hip fracture rates and subsequent mortality among persons 65 years and older are declining, and comorbidities among patients with hip fractures have increased.

[1]  J. Avrunin,et al.  Trends in hospital care for hip fractures , 2007, Osteoporosis International.

[2]  M. Vessey,et al.  RISING INCIDENCE OF FRACTURE OF THE PROXIMAL FEMUR , 1985, The Lancet.

[3]  Y. Carter,et al.  Education and debate , 2022 .

[4]  R. Burge,et al.  Methodology for estimating current and future burden of osteoporosis in state populations: application to Florida in 2000 through 2025. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  O. Johnell,et al.  The components of excess mortality after hip fracture. , 2003, Bone.

[6]  H. Handoll,et al.  Replacement arthroplasty versus internal fixation for extracapsular hip fractures. , 2000, The Cochrane database of systematic reviews.

[7]  J. Empana,et al.  Effect of Hip Fracture on Mortality in Elderly Women: The EPIDOS Prospective Study , 2004, Journal of the American Geriatrics Society.

[8]  H. Handoll,et al.  Mobilisation strategies after hip fracture surgery in adults. , 2003, The Cochrane database of systematic reviews.

[9]  C. Sledge,et al.  Hip fracture mortality. Relation to age, treatment, preoperative illness, time of surgery, and complications. , 1984, Clinical orthopaedics and related research.

[10]  J L Warren,et al.  Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.

[11]  Stephen E Roberts,et al.  Mortality after admission to hospital with fractured neck of femur: database study , 2002, BMJ : British Medical Journal.

[12]  Pekka Kannus,et al.  Hip fractures in Finland between 1970 and 1997 and predictions for the future , 1999, The Lancet.

[13]  Stephen E Roberts,et al.  Time trends and demography of mortality after fractured neck of femur in an English population, 1968–98: database study , 2003, BMJ : British Medical Journal.

[14]  Sirpa Hartikainen,et al.  Use of medications and polypharmacy are increasing among the elderly. , 2002, Journal of clinical epidemiology.

[15]  C. Moran,et al.  Early mortality after hip fracture: is delay before surgery important? , 2005, The Journal of bone and joint surgery. American volume.

[16]  C. Cooper,et al.  The crippling consequences of fractures and their impact on quality of life. , 1997, The American journal of medicine.

[17]  H. Quan,et al.  Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data , 2005, Medical care.

[18]  H. Handoll,et al.  Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults. , 2005, The Cochrane database of systematic reviews.

[19]  G. Hawker,et al.  Population Trends in BMD Testing, Treatment, and Hip and Wrist Fracture Rates: Are the Hip Fracture Projections Wrong? , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  H. Handoll,et al.  Replacement arthroplasty versus internal fixation for extracapsular hip fractures in adults. , 2006, The Cochrane database of systematic reviews.

[21]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[22]  P. Goldswain,et al.  Hip fracture outcomes: quality of life and functional status in older adults living in the community. , 2000, Australian and New Zealand journal of medicine.

[23]  E. Feuer,et al.  Confidence intervals for directly standardized rates: a method based on the gamma distribution. , 1997, Statistics in medicine.

[24]  R. Rizzoli,et al.  Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend. , 2007, Bone.

[25]  J. Eisman,et al.  Incidence of Hip and Other Osteoporotic Fractures in Elderly Men and Women: Dubbo Osteoporosis Epidemiology Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  Philippe Autier,et al.  Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study , 2004, Osteoporosis International.

[27]  R. Pascual,et al.  Contemporary Issues in the Care of Patients With Chronic Obstructive Pulmonary Disease , 2005, Journal of managed care pharmacy : JMCP.

[28]  K. Choi.  [Hip fracture]. , 1963, [Chapchi] Journal. Taehan Oekwa Hakhoe.

[29]  A. Tosteson,et al.  Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025 , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  R. Stafford,et al.  National trends in osteoporosis visits and osteoporosis treatment, 1988-2003. , 2004, Archives of internal medicine.

[31]  O. Löfman,et al.  Changes in Hip Fracture Epidemiology: Redistribution Between Ages, Genders and Fracture Types , 2002, Osteoporosis International.

[32]  J. Eisman,et al.  Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. , 2009, JAMA.

[33]  J. Cauley,et al.  Risk of Mortality Following Clinical Fractures , 2000, Osteoporosis International.

[34]  A. Tosteson,et al.  Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations. , 2008, The American journal of managed care.

[35]  J. F. Fitzgerald,et al.  The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study. , 1997, American journal of public health.

[36]  J. Zuckerman,et al.  Temporal and geographic variation in hip fracture rates for people aged 65 or older, New York State, 1985-1996. , 2005, American journal of orthopedics.

[37]  I. Kiviranta,et al.  Increased incidence of hip fractures. A population based-study in Finland. , 2006, Bone.

[38]  S. Silverman,et al.  Deterioration in Quality of Life Following Hip Fracture: A Prospective Study , 2000, Osteoporosis International.

[39]  E. Fisher,et al.  Comorbidity risk-adjustment strategies are comparable among persons with hip fracture. , 2008, Journal of clinical epidemiology.

[40]  T. Therneau,et al.  Secular trends in hip fracture incidence and recurrence , 2009, Osteoporosis International.

[41]  R. Goodman,et al.  The effect of risedronate on the risk of hip fracture in elderly women. , 2001, The New England journal of medicine.

[42]  S. Gabriel,et al.  Cost-equivalence of different osteoporotic fractures , 2003, Osteoporosis International.

[43]  K. Gurusamy,et al.  Arthroplasties (with and without bone cement) for proximal femoral fractures in adults. , 2004, The Cochrane database of systematic reviews.

[44]  R. Rizzoli,et al.  Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients , 1994, Osteoporosis International.

[45]  W. Leslie,et al.  Trends in hip fracture rates in Canada. , 2009, JAMA.

[46]  P Geusens,et al.  Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. , 2001, The New England journal of medicine.

[47]  C. Cooper,et al.  Epidemiology of fractures in England and Wales. , 2001, Bone.

[48]  O. Johnell,et al.  An estimate of the worldwide prevalence, mortality and disability associated with hip fracture , 2004, Osteoporosis International.

[49]  S. Silverman,et al.  Increasing hip fracture incidence in California Hispanics, 1983 to 2000 , 2004, Osteoporosis International.

[50]  J. Eisman,et al.  Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. , 2009, JAMA.

[51]  C. Cooper,et al.  Hip fractures in the elderly: A world-wide projection , 1992, Osteoporosis International.

[52]  R. Epstein,et al.  Excess mortality attributable to hip fracture in white women aged 70 years and older. , 1997, American journal of public health.

[53]  R. Rizzoli,et al.  Protein Supplements Increase Serum Insulin-Like Growth Factor-I Levels and Attenuate Proximal Femur Bone Loss in Patients with Recent Hip Fracture , 1998, Annals of Internal Medicine.

[54]  H. Handoll,et al.  Mobilisation strategies after hip fracture surgery in adults. , 2000, The Cochrane database of systematic reviews.

[55]  S. Kirsh,et al.  Perioperative care of the geriatric patient with diabetes or hyperglycemia. , 2008, Clinics in geriatric medicine.

[56]  B. Kopjar,et al.  Survival after Hip Fracture: Short- and Long-Term Excess Mortality According to Age and Gender , 1999, Osteoporosis International.

[57]  J. Zuckerman,et al.  Mortality Risk After Hip Fracture , 2003, Journal of orthopaedic trauma.

[58]  M. Schwenkglenks,et al.  A model of osteoporosis impact in Switzerland 2000–2020 , 2005, Osteoporosis International.

[59]  H. Pols,et al.  Fractures in the elderly: epidemiology and demography. , 2000, Bailliere's best practice & research. Clinical endocrinology & metabolism.

[60]  P. Vestergaard,et al.  Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications , 2007, Osteoporosis International.

[61]  N. Endo,et al.  Incidence and outcome of osteoporotic fractures in 2004 in Sado City, Niigata Prefecture, Japan , 2008, Journal of Bone and Mineral Metabolism.